ProMed Pharma is your distinguished development partner in long-acting injectable and implantable dosage forms. With nearly 20 years of operational history, we have honed our expertise in polymer-based dosage forms, achieving mastery in extended-release dosing. Our proficiency spans molding, extrusion, and microencapsulation techniques, leveraging a diverse spectrum of polymeric excipients including silicones, thermoplastics, and biodegradables.
Polymeric drug delivery technologies offer several advantages over conventional oral or parenteral dosage forms. First, implantable devices allow site specific drug administration where the drug is most needed. This may also allow for significantly lower doses of drug which can minimize potential side effects.
ProMed is a trusted partner from early-stage formulation and tech transfer, through preclinical, tox and early-stage clinical trial supply, to commercial manufacturing. Our commitment to rapid project execution is underpinned by a steadfast dedication to scientific inquiry and technical finesse.
LSR and HCR conductive silicone enables new devices from medical wearables for novel therapeutic treatments to specialized parts for aerospace and automotive applications.
